Stephen Staal

1.5k total citations · 1 hit paper
15 papers, 1.2k citations indexed

About

Stephen Staal is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Stephen Staal has authored 15 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Pathology and Forensic Medicine and 3 papers in Surgery. Recurrent topics in Stephen Staal's work include Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and PARP inhibition in cancer therapy (3 papers). Stephen Staal is often cited by papers focused on Chronic Lymphocytic Leukemia Research (3 papers), Lymphoma Diagnosis and Treatment (3 papers) and PARP inhibition in cancer therapy (3 papers). Stephen Staal collaborates with scholars based in United States. Stephen Staal's co-authors include Joseph R. Testa, Philip N. Tsichlis, Alfonso Bellacosa, Risa B. Mann, William E. Beschorner, Gail Hayward, Richard F. Ambinder, James A. Hoch, Wallace P. Rowe and Jerry L. Spivak and has published in prestigious journals such as Science, Journal of Clinical Oncology and Cancer.

In The Last Decade

Stephen Staal

14 papers receiving 1.1k citations

Hit Papers

A Retroviral Oncogene, akt , Encoding a Serine-Threonine ... 1991 2026 2002 2014 1991 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Retroviral Oncogene, akt , Encoding a Serine-Threonine Kinase Containing an SH2-Like Region
    1991 720 citations Alfonso Bellacosa, Joseph R. Testa et al. Science profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stephen Staal United States 10 709 344 321 147 117 15 1.2k
John F. DeCoteau Canada 24 903 1.3× 401 1.2× 372 1.2× 130 0.9× 134 1.1× 63 1.5k
Alexander L. Kovalchuk United States 21 616 0.9× 291 0.8× 157 0.5× 398 2.7× 105 0.9× 53 1.2k
David Klinkebiel United States 18 691 1.0× 258 0.8× 216 0.7× 320 2.2× 65 0.6× 35 1.1k
Sylvia Rothenberger Switzerland 22 567 0.8× 429 1.2× 278 0.9× 248 1.7× 115 1.0× 47 1.6k
Takeshi Ueda Japan 18 1.3k 1.8× 204 0.6× 121 0.4× 202 1.4× 111 0.9× 39 1.5k
Doris A. Phelps United States 20 832 1.2× 362 1.1× 80 0.2× 97 0.7× 137 1.2× 36 1.3k
Lucia Mazzacurati United States 14 550 0.8× 387 1.1× 88 0.3× 128 0.9× 73 0.6× 22 956
M Pettersson Sweden 21 1.3k 1.8× 424 1.2× 96 0.3× 229 1.6× 187 1.6× 25 1.8k
Megan Keniry United States 17 1.2k 1.7× 318 0.9× 152 0.5× 106 0.7× 80 0.7× 38 1.5k
Mercedes Gallardo Spain 13 1.1k 1.5× 500 1.5× 95 0.3× 248 1.7× 85 0.7× 14 1.7k

Countries citing papers authored by Stephen Staal

Since Specialization
Citations

This map shows the geographic impact of Stephen Staal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen Staal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen Staal more than expected).

Fields of papers citing papers by Stephen Staal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen Staal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen Staal. The network helps show where Stephen Staal may publish in the future.

Co-authorship network of co-authors of Stephen Staal

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen Staal. A scholar is included among the top collaborators of Stephen Staal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen Staal. Stephen Staal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
George, Thomas J., Ji‐Hyun Lee, Peter J. Hosein, et al.. (2022). Results of a phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response pathway deficient neoplasms.. Journal of Clinical Oncology. 40(16_suppl). 3122–3122. 16 indexed citations
2.
Wang, Shu, Ryan M. Thomas, Brian Hemendra Ramnaraign, et al.. (2022). A phase II randomized therapeutic optimization trial for subjects with refractory metastatic colorectal cancer using circulating tumor DNA (ctDNA): Rapid 1 trial.. Journal of Clinical Oncology. 40(4_suppl). TPS223–TPS223. 1 indexed citations
3.
George, Thomas J., David L. DeRemer, Ji‐Hyun Lee, et al.. (2021). Phase II trial of the PARP inhibitor, niraparib, in BRCA1-Associated Protein 1 (BAP1) and other DNA damage response (DDR) pathway deficient neoplasms including cholangiocarcinoma.. Journal of Clinical Oncology. 39(3_suppl). TPS354–TPS354. 2 indexed citations
4.
Drane, Walter E., et al.. (2020). SAT-190 Are Pet Scans Needed in Evaluating Lipid Rich Adrenal Adenomas?. Journal of the Endocrine Society. 4(Supplement_1).
5.
George, Thomas J., David L. DeRemer, Hiral D. Parekh, et al.. (2020). Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms including cholangiocarcinoma.. Journal of Clinical Oncology. 38(4_suppl). TPS591–TPS591. 10 indexed citations
6.
DeRemer, David L., Ji‐Hyun Lee, Hiral D. Parekh, et al.. (2020). Phase II trial of the PARP inhibitor, niraparib, in BAP1 and other DNA damage response (DDR) pathway deficient neoplasms (NCT03207347).. Journal of Clinical Oncology. 38(15_suppl). e22061–e22061. 2 indexed citations
7.
Staal, Stephen, et al.. (2010). Liposomal Doxorubicin and nab-Paclitaxel: Nanoparticle Cancer Chemotherapy in Current Clinical Use. Methods in molecular biology. 624. 385–392. 49 indexed citations
8.
Bellacosa, Alfonso, Joseph R. Testa, Stephen Staal, & Philip N. Tsichlis. (1991). A Retroviral Oncogene, akt , Encoding a Serine-Threonine Kinase Containing an SH2-Like Region. Science. 254(5029). 274–277. 720 indexed citations breakdown →
9.
Staal, Stephen, Richard F. Ambinder, William E. Beschorner, Gail Hayward, & Risa B. Mann. (1989). A Survey of Epstein-Barr Virus DNA in Lymphoid Tissue: Frequent Detection in Hodgkin’s Disease. American Journal of Clinical Pathology. 91(1). 1–5. 189 indexed citations
10.
Dement, Samuel H., Risa B. Mann, Stephen Staal, Francis P. Kuhajda, & John K. Boitnott. (1987). Primary Lymphomas of the Liver: Report of Six Cases and Review of the Literature. American Journal of Clinical Pathology. 88(3). 255–263. 45 indexed citations
11.
Misawa, S, Stephen Staal, & Joseph R. Testa. (1987). Amplification of the c-myc Oncogene is associated with an abnormally banded region on chromosome 8 or double minute chromosomes in two HL-60 human leukemia sublines. Cancer Genetics and Cytogenetics. 28(1). 127–135. 28 indexed citations
12.
McDonnell, Jan M., William E. Beschorner, Stephen Staal, Jerry L. Spivak, & Risa B. Mann. (1986). Richter's syndrome with two different B-cell clones. Cancer. 58(9). 2031–2037. 47 indexed citations
13.
Staal, Stephen & Wallace P. Rowe. (1975). Enhancement of adenovirus infection in WI-38 and AGMK cells by pretreatment of cells with 5-lododeoxyuridine. Virology. 64(2). 513–519. 17 indexed citations
14.
Staal, Stephen & Wallace P. Rowe. (1974). Differential Effect of Phenethyl Alcohol on Mycoplasmas and Enveloped Viruses. Journal of Virology. 14(6). 1620–1622. 6 indexed citations
15.
Staal, Stephen, et al.. (1973). Phenotypes of Pleiotropic-Negative Sporulation Mutants of Bacillus subtilis. Journal of Bacteriology. 115(3). 1063–1070. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John F. DeCoteau Breakdown of academic impact, for papers by Alexander L. Kovalchuk Breakdown of academic impact, for papers by David Klinkebiel Breakdown of academic impact, for papers by Sylvia Rothenberger Breakdown of academic impact, for papers by Takeshi Ueda Breakdown of academic impact, for papers by Doris A. Phelps Breakdown of academic impact, for papers by Lucia Mazzacurati Breakdown of academic impact, for papers by M Pettersson Breakdown of academic impact, for papers by Megan Keniry Breakdown of academic impact, for papers by Mercedes Gallardo
Rankless by CCL
2026